This is a Validated Antibody Database (VAD) review about human MAML2, based on 6 published articles (read how Labome selects the articles), using MAML2 antibody in all methods. It is aimed to help Labome visitors find the most suited MAML2 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
MAML2 synonym: MAM-3; MAM2; MAM3; MLL-MAML2; mastermind-like protein 2; mam-2; mastermind-like 2

Bethyl
rabbit polyclonal
  • western blot; human
In order to study the role of MAML3 in proliferation and retinoic acid-mediated differentiation, Bethyl MAML2 antibody (Bethyl Laboratories, A300-682A) was used in western blot on human samples . Mol Cancer Res (2016) ncbi
rabbit polyclonal
  • western blot; human
Bethyl MAML2 antibody (Bethyl, A300-681A) was used in western blot on human samples . Proc Natl Acad Sci U S A (2014) ncbi
rabbit polyclonal
  • chromatin immunoprecipitation; human; fig 3
  • western blot; human; fig 1
Bethyl MAML2 antibody (Bethyl Laboratories, A300-681A) was used in chromatin immunoprecipitation on human samples (fig 3) and in western blot on human samples (fig 1). Oncogene (2014) ncbi
Cell Signaling Technology
rabbit monoclonal (D41E6)
  • western blot; mouse; 1:1000; loading ...; fig s12c
In order to investigate the impact of locked nucleic acid-modified antisense oligonucleotide complementary to the CAG repeat on Huntington's disease, Cell Signaling Technology MAML2 antibody (Cell Signaling, 6988) was used in western blot on mouse samples at 1:1000 (fig s12c). J Clin Invest (2016) ncbi
rabbit polyclonal
  • western blot; human
Cell Signaling Technology MAML2 antibody (Cell Signaling, 4618) was used in western blot on human samples . Proc Natl Acad Sci U S A (2014) ncbi
rabbit monoclonal (D41E6)
  • western blot; human; 1:500
In order to investigate the signalling pathways involved in the development of invasive trophoblasts, Cell Signaling Technology MAML2 antibody (Cell Signalling, 6988) was used in western blot on human samples at 1:500. Mol Hum Reprod (2014) ncbi
rabbit polyclonal
  • chromatin immunoprecipitation; human; fig 3
  • western blot; human; fig 1
Cell Signaling Technology MAML2 antibody (Cell Signaling Technology, CST-4618) was used in chromatin immunoprecipitation on human samples (fig 3) and in western blot on human samples (fig 1). Oncogene (2014) ncbi
Sigma-Aldrich
mouse monoclonal (4A1)
  • other; human; loading ...; fig st1
In order to use size exclusion chromatography-microsphere-based affinity proteomics to study clinical samples obtained from pediatric acute leukemia patients, Sigma-Aldrich MAML2 antibody (SIGMA, 4A1) was used in other on human samples (fig st1). Mol Cell Proteomics (2016) ncbi
Articles Reviewed
  1. Rue L, Bañez Coronel M, Creus Muncunill J, Giralt A, Alcalá Vida R, Mentxaka G, et al. Targeting CAG repeat RNAs reduces Huntington's disease phenotype independently of huntingtin levels. J Clin Invest. 2016;126:4319-4330 pubmed publisher
  2. Heynen G, Nevedomskaya E, Palit S, Jagalur Basheer N, Lieftink C, Schlicker A, et al. Mastermind-Like 3 Controls Proliferation and Differentiation in Neuroblastoma. Mol Cancer Res. 2016;14:411-22 pubmed publisher
  3. Kanderová V, Kuzilkova D, Stuchly J, Vaskova M, Brdicka T, Fiser K, et al. High-resolution Antibody Array Analysis of Childhood Acute Leukemia Cells. Mol Cell Proteomics. 2016;15:1246-61 pubmed publisher
  4. Amelio A, Fallahi M, Schaub F, Zhang M, Lawani M, Alperstein A, et al. CRTC1/MAML2 gain-of-function interactions with MYC create a gene signature predictive of cancers with CREB-MYC involvement. Proc Natl Acad Sci U S A. 2014;111:E3260-8 pubmed publisher
  5. Velicky P, Haider S, Otti G, Fiala C, Pollheimer J, Knöfler M. Notch-dependent RBPJ? inhibits proliferation of human cytotrophoblasts and their differentiation into extravillous trophoblasts. Mol Hum Reprod. 2014;20:756-66 pubmed publisher
  6. Chen Z, Chen J, Gu Y, Hu C, Li J, Lin S, et al. Aberrantly activated AREG-EGFR signaling is required for the growth and survival of CRTC1-MAML2 fusion-positive mucoepidermoid carcinoma cells. Oncogene. 2014;33:3869-77 pubmed publisher